183 related articles for article (PubMed ID: 32154327)
1. Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice.
Gallinaro A; Borghi M; Pirillo MF; Cecchetti S; Bona R; Canitano A; Michelini Z; Di Virgilio A; Olvera A; Brander C; Negri D; Cara A
Mol Ther Methods Clin Dev; 2020 Jun; 17():418-428. PubMed ID: 32154327
[TBL] [Abstract][Full Text] [Related]
2. Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.
Negri D; Blasi M; LaBranche C; Parks R; Balachandran H; Lifton M; Shen X; Denny T; Ferrari G; Vescio MF; Andersen H; Montefiori DC; Tomaras GD; Liao HX; Santra S; Haynes BF; Klotman ME; Cara A
Mol Ther; 2016 Nov; 24(11):2021-2032. PubMed ID: 27455880
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization.
Bona R; Michelini Z; Mazzei C; Gallinaro A; Canitano A; Borghi M; Vescio MF; Di Virgilio A; Pirillo MF; Klotman ME; Negri D; Cara A
Mol Ther Methods Clin Dev; 2021 Dec; 23():263-275. PubMed ID: 34729374
[TBL] [Abstract][Full Text] [Related]
4. Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.
Gallinaro A; Borghi M; Bona R; Grasso F; Calzoletti L; Palladino L; Cecchetti S; Vescio MF; Macchia D; Morante V; Canitano A; Temperton N; Castrucci MR; Salvatore M; Michelini Z; Cara A; Negri D
Front Immunol; 2018; 9():171. PubMed ID: 29459873
[TBL] [Abstract][Full Text] [Related]
5. Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers.
Gallinaro A; Pirillo MF; Aldon Y; Cecchetti S; Michelini Z; Tinari A; Borghi M; Canitano A; McKay PF; Bona R; Vescio MF; Grasso F; Blasi M; Baroncelli S; Scarlatti G; LaBranche C; Montefiori D; Klotman ME; Sanders RW; Shattock RJ; Negri D; Cara A
NPJ Vaccines; 2022 Apr; 7(1):44. PubMed ID: 35449174
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques.
Blasi M; Wescott EC; Baker EJ; Mildenberg B; LaBranche C; Rountree W; Haynes BF; Saunders KO; Moody MA; Negri D; Santra S; Cara A; Klotman ME
NPJ Vaccines; 2020; 5(1):36. PubMed ID: 32411399
[TBL] [Abstract][Full Text] [Related]
7. A Novel Immunogen Selectively Eliciting CD8
Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
[TBL] [Abstract][Full Text] [Related]
8. A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.
Mothe B; Hu X; Llano A; Rosati M; Olvera A; Kulkarni V; Valentin A; Alicea C; Pilkington GR; Sardesai NY; Rocafort M; Crespo M; Carrillo J; Marco A; Mullins JI; Dorrell L; Hanke T; Clotet B; Pavlakis GN; Felber BK; Brander C
J Transl Med; 2015 Feb; 13():60. PubMed ID: 25879820
[TBL] [Abstract][Full Text] [Related]
9. IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells.
Blasi M; Negri D; LaBranche C; Alam SM; Baker EJ; Brunner EC; Gladden MA; Michelini Z; Vandergrift NA; Wiehe KJ; Parks R; Shen X; Bonsignori M; Tomaras GD; Ferrari G; Montefiori DC; Santra S; Haynes BF; Moody MA; Cara A; Klotman ME
Commun Biol; 2018; 1():134. PubMed ID: 30272013
[TBL] [Abstract][Full Text] [Related]
10. Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines.
Negri DR; Rossi A; Blasi M; Michelini Z; Leone P; Chiantore MV; Baroncelli S; Perretta G; Cimarelli A; Klotman ME; Cara A
Retrovirology; 2012 Aug; 9():69. PubMed ID: 22913641
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.
Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A
Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664
[TBL] [Abstract][Full Text] [Related]
12. Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses.
Mahesh S; Li J; Travieso T; Psaradelli D; Negri D; Klotman M; Cara A; Blasi M
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005931
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs.
Blasi M; Negri D; Saunders KO; Baker EJ; Stadtler H; LaBranche C; Mildenberg B; Morton G; Ciarla A; Shen X; Wang Y; Rountree W; Balakumaran B; Santra S; Haynes BF; Moody AM; Cara A; Klotman ME
NPJ Vaccines; 2020 Nov; 5(1):107. PubMed ID: 33298954
[TBL] [Abstract][Full Text] [Related]
14. Murine granulocyte-macrophage colony-stimulating factor expressed from a bicistronic simian immunodeficiency virus-based integrase-defective lentiviral vector does not enhance T-cell responses in mice.
Michelini Z; Negri D; Biava M; Baroncelli S; Spada M; Leone P; Bona R; Blasi M; Nègre D; Klotman ME; Cara A
Viral Immunol; 2014 Dec; 27(10):512-20. PubMed ID: 25343523
[TBL] [Abstract][Full Text] [Related]
15. Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.
Negri DR; Michelini Z; Bona R; Blasi M; Filati P; Leone P; Rossi A; Franco M; Cara A
Expert Opin Biol Ther; 2011 Jun; 11(6):739-50. PubMed ID: 21434847
[TBL] [Abstract][Full Text] [Related]
16. Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles.
Borghi M; Gallinaro A; Pirillo MF; Canitano A; Michelini Z; De Angelis ML; Cecchetti S; Tinari A; Falce C; Mariotti S; Capocefalo A; Chiantore MV; Iacobino A; Di Virgilio A; van Gils MJ; Sanders RW; Lo Presti A; Nisini R; Negri D; Cara A
Front Immunol; 2023; 14():1147953. PubMed ID: 37090707
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
18. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
19. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2017 May; 91(9):. PubMed ID: 28179536
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.
Martins MA; Bonaldo MC; Rudersdorf RA; Piaskowski SM; Rakasz EG; Weisgrau KL; Furlott JR; Eernisse CM; Veloso de Santana MG; Hidalgo B; Friedrich TC; Chiuchiolo MJ; Parks CL; Wilson NA; Allison DB; Galler R; Watkins DI
PLoS One; 2013; 8(1):e54434. PubMed ID: 23336000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
